A new porcine syndrome, which had previously been observed primarily on guinea pig farms, is now being detected in more European countries.
According to Food & Agribusiness, a Danish research team recently confirmed that a sow farm in Denmark exhibited clinical symptoms similar to those seen in the Dutch cases and tested positive for a highly similar variant of a new parvovirus. This development suggests that this new issue, which first drew attention at pig farms in the Netherlands, may no longer be confined to a single country.
From the Netherlands to Denmark: A New Syndrome Begins to Emerge Across Borders
This incident can be traced back to the Netherlands.
According to public reports, an abnormal piglet syndrome began appearing on Dutch pig farms in late 2024, primarily affecting young pigs. Typical symptoms included protruding eyes, mild strabismus, skin redness, hair loss, skin wrinkling, growth retardation, post-weaning diarrhea, and some nonspecific respiratory symptoms.
By mid-2025, the Dutch animal health agency Royal GD reported that related issues had been detected at approximately 50 pig farms. At that time, researchers identified a new variant of the parvovirus—previously unconfirmed in pigs—in the tissues and blood of affected pigs.
In May 2026, at the European Symposium on Pig Health Management (ESPHM) held in Florence, Italy, Royal GD researcher Tijs Tobias provided an update: this syndrome had been observed in an increasing number of pig farms in the Netherlands, and its estimated scope was likely quite extensive. Tobias also concluded that the syndrome was unlikely to be confined solely to the Netherlands.
This conclusion was soon supported by new evidence.
Institutions including the University of Copenhagen in Denmark subsequently reported the discovery of similar cases at a sow farm in Denmark. Approximately 1.5%–2% of the piglets and weaners at that farm exhibited similar clinical signs. The research team performed necropsies on six 1–2-week-old piglets and detected the virus in their livers and spleens. Sequencing results showed that the viral strain from the Danish pig farm was highly similar to the strain circulating in the Netherlands.
Virus Evidence Points to a Novel Parvovirus, but the Cause Has Not Yet Been Fully Confirmed
Currently, key evidence in this case points to a new parvovirus variant. Reports often refer to it as the “novel parvovirus variant” or “nPPV.”
It is important to note that this virus is not porcine parvovirus type 1 (PPV1) in the traditional sense. PPV1 is one of the common pathogens found on pig farms and is primarily associated with reproductive disorders in sows; existing vaccines are mainly designed to target this type. The newly detected virus is genetically distinct from PPV1; therefore, existing PPV1 vaccines are not expected to provide effective protection, and standard PPV testing methods may not be able to detect it.
This is also what makes this incident cause for concern: if pig farms treat the situation solely based on the traditional understanding of porcine parvovirus, they may underestimate this new variant.
However, based on currently available public information, the research community remains cautious about the cause of the disease. Although the new parvovirus has been detected in multiple symptomatic pigs and is highly correlated with cases in the Netherlands and Denmark, “detecting the virus” does not equate to fully proving that “the virus is the sole cause of all symptoms” .
In other words, the more accurate assessment at this time is that this syndrome is strongly associated with a new parvovirus variant, but its complete pathogenic mechanism, transmission routes, and clinical consequences still require further research to confirm.
A preprint published by the Danish team on bioRxiv also emphasizes that the study has not yet undergone peer review. The preprint shows that the virus in question was detected not only in symptomatic pigs in Denmark but also in samples from Danish foxes. However, the genetic relationship between the viruses found on pig farms is closer than that between them and viruses from local wildlife, suggesting a possible epidemiological link between the cases on pig farms in the Netherlands and Denmark.
Wildlife Clues Are Complex; Foxes May Play a Role in the Virus’s Ecology
Another sensitive issue regarding this new virus is the wildlife connection.
As early as 2012, a parvovirus similar to the current virus was detected in fox feces samples from the Netherlands. In the latest Danish study, researchers detected the virus in 2 out of 80 Danish fox spleen samples.
This suggests that foxes or other wild animals may be linked in some way to the virus’s natural ecology.
However, it is still too early to simply conclude that “foxes transmit the virus to pigs.” The detection of the virus in fox samples could mean that the foxes were infected and replicating the virus, or it could simply indicate temporary viral carriage following predation or environmental exposure. The Danish team also noted that the virus’s pathogenic role in wild animals remains unknown.
More noteworthy is that the viral strains from pig farms in the Netherlands and Denmark are highly similar to each other—even more closely related than they are to viruses found in local wildlife. This suggests a transmission link among pig herds rather than independent spillovers from local wildlife in each country.
If follow-up research confirms this, the focus of the investigation will shift from “occasional spillovers from wildlife” to “transnational transmission within pig herds or related supply chains.”
Cases Have Also Been Detected in Belgium, Germany, and Spain
In addition to Denmark, related reports mention that the virus and the syndrome have been detected at pig farms in Belgium and Germany. An update from PathoSense Diagnostics also states that the virus has been detected in Spain.
This indicates that monitoring efforts are expanding across Europe.
However, publicly available information remains limited at this time. For the cases in Belgium, Germany, and Spain, there is still a lack of detailed data on on-farm epidemiology, clinical severity, viral load, transmission chains, and economic losses. Therefore, it cannot yet be directly defined as a “European pandemic.”
A more prudent statement would be: this new swine syndrome and the associated virus have been detected in multiple European countries, and the scope of transmission and clinical impact are still being confirmed.
A Low Mortality Rate Does Not Equate to Low Losses
Based on current reports, this syndrome is not primarily characterized by a high mortality rate. The Dutch case report also noted that the mortality rate is generally low, with the disease course on a single farm potentially lasting 3–6 months, after which some degree of natural immunity appears to develop.
However, a low mortality rate does not mean that the impact on the industry can be ignored.
The problem with this disease is that it primarily affects piglets and young pigs, manifesting as skin abnormalities, stunted growth, post-weaning diarrhea, and respiratory symptoms. For pig farms, these issues may not necessarily result in large-scale mortality, but they can lead to more subtle production losses:
• Decreased uniformity among piglets;
• Slower growth rates;
• Increased difficulty in post-weaning management;
• Higher proportion of weak and stunted piglets;
• Increased diagnostic costs;
• Losses may be magnified when co-infected with other pathogens.
For intensive pig farms, this type of “survival but poor growth” issue is often harder to identify quickly than a single episode of high mortality, and is more likely to be attributed to management, nutrition, or common pathogen pressure.
A Reminder for China’s Swine Industry
To date, there have been no public reports of similar cases at Chinese pig farms, and there is no need to cause panic.
However, this incident in Europe offers at least three lessons for the domestic swine industry.
First, a new pathogen does not necessarily begin with a high mortality rate.
Many new issues initially manifest as skin abnormalities, stunted growth, post-weaning diarrhea, or uneven growth rates among litters, rather than mass deaths. If pig farms focus solely on mortality rates, they may miss these early warning signs.
Second, a negative result on routine testing does not necessarily mean the absence of a new pathogen.
This novel parvovirus differs from the classic PPV1, and routine PPV testing may not detect it. If clinical symptoms persist but cannot be explained by routine pathogen testing, more advanced pathogen detection methods, such as metagenomic sequencing, should be considered.
Third, vigilance must be maintained regarding cross-border breeding stock, semen, and related supply chains.
If it is confirmed in the future that this virus has spread widely among European pig populations and can spread across regions through pig trade or biological materials, then the entire chain—including breeding stock, semen, personnel, vehicles, and equipment—may become a key focus of prevention and control assessments.
Industry Assessment: Strong Correlation, Cause Undetermined; Has Spread Across Countries, Transmission Chain Unclear
Based on current information, the timeline of this incident is now relatively clear:
First, a guinea pig farm in the Netherlands reported abnormal piglet syndrome in late 2024; Subsequently, in mid-2025, Royal GD reported that approximately 50 pig farms were affected and detected a new variant of the parvovirus; By 2026, the scope of the outbreak in the Netherlands had expanded further; subsequently, Denmark detected a highly similar virus in comparable cases; and recently, reports of detections have also emerged from Belgium, Germany, and Spain.
This is not a major epidemic that has been fully characterized, but neither is it a minor news item to be taken lightly.
There are currently three key issues:
1. Whether this novel parvovirus can consistently reproduce clinical symptoms in challenge trials;
2. Whether there is a common transmission chain linking cases across multiple European countries;
3. Whether the virus can spread across regions via breeding stock, semen, or other commercial channels.
Until these questions are answered, the most prudent assessment for the industry is:
This is a newly emerging porcine syndrome in Europe strongly associated with the novel parvovirus. While it has been detected across national borders, the causal relationship, transmission routes, and production losses are still being confirmed. For pig farms, the greatest risk is not high mortality, but rather the chronic production losses and diagnostic blind spots underlying the low mortality rate.
Disclaimer: Some of the information in this article is sourced from the internet. Sources have been clearly cited, and copyright belongs to the original authors. The content is provided for readers’ reference only. If the rights of the original authors have been infringed, please contact us promptly via comment so we may remove the content!
According to Food & Agribusiness, a Danish research team recently confirmed that a sow farm in Denmark exhibited clinical symptoms similar to those seen in the Dutch cases and tested positive for a highly similar variant of a new parvovirus. This development suggests that this new issue, which first drew attention at pig farms in the Netherlands, may no longer be confined to a single country.
From the Netherlands to Denmark: A New Syndrome Begins to Emerge Across Borders
This incident can be traced back to the Netherlands.
According to public reports, an abnormal piglet syndrome began appearing on Dutch pig farms in late 2024, primarily affecting young pigs. Typical symptoms included protruding eyes, mild strabismus, skin redness, hair loss, skin wrinkling, growth retardation, post-weaning diarrhea, and some nonspecific respiratory symptoms.
By mid-2025, the Dutch animal health agency Royal GD reported that related issues had been detected at approximately 50 pig farms. At that time, researchers identified a new variant of the parvovirus—previously unconfirmed in pigs—in the tissues and blood of affected pigs.
In May 2026, at the European Symposium on Pig Health Management (ESPHM) held in Florence, Italy, Royal GD researcher Tijs Tobias provided an update: this syndrome had been observed in an increasing number of pig farms in the Netherlands, and its estimated scope was likely quite extensive. Tobias also concluded that the syndrome was unlikely to be confined solely to the Netherlands.
This conclusion was soon supported by new evidence.
Institutions including the University of Copenhagen in Denmark subsequently reported the discovery of similar cases at a sow farm in Denmark. Approximately 1.5%–2% of the piglets and weaners at that farm exhibited similar clinical signs. The research team performed necropsies on six 1–2-week-old piglets and detected the virus in their livers and spleens. Sequencing results showed that the viral strain from the Danish pig farm was highly similar to the strain circulating in the Netherlands.
Virus Evidence Points to a Novel Parvovirus, but the Cause Has Not Yet Been Fully Confirmed
Currently, key evidence in this case points to a new parvovirus variant. Reports often refer to it as the “novel parvovirus variant” or “nPPV.”
It is important to note that this virus is not porcine parvovirus type 1 (PPV1) in the traditional sense. PPV1 is one of the common pathogens found on pig farms and is primarily associated with reproductive disorders in sows; existing vaccines are mainly designed to target this type. The newly detected virus is genetically distinct from PPV1; therefore, existing PPV1 vaccines are not expected to provide effective protection, and standard PPV testing methods may not be able to detect it.
This is also what makes this incident cause for concern: if pig farms treat the situation solely based on the traditional understanding of porcine parvovirus, they may underestimate this new variant.
However, based on currently available public information, the research community remains cautious about the cause of the disease. Although the new parvovirus has been detected in multiple symptomatic pigs and is highly correlated with cases in the Netherlands and Denmark, “detecting the virus” does not equate to fully proving that “the virus is the sole cause of all symptoms” .
In other words, the more accurate assessment at this time is that this syndrome is strongly associated with a new parvovirus variant, but its complete pathogenic mechanism, transmission routes, and clinical consequences still require further research to confirm.
A preprint published by the Danish team on bioRxiv also emphasizes that the study has not yet undergone peer review. The preprint shows that the virus in question was detected not only in symptomatic pigs in Denmark but also in samples from Danish foxes. However, the genetic relationship between the viruses found on pig farms is closer than that between them and viruses from local wildlife, suggesting a possible epidemiological link between the cases on pig farms in the Netherlands and Denmark.
Wildlife Clues Are Complex; Foxes May Play a Role in the Virus’s Ecology
Another sensitive issue regarding this new virus is the wildlife connection.
As early as 2012, a parvovirus similar to the current virus was detected in fox feces samples from the Netherlands. In the latest Danish study, researchers detected the virus in 2 out of 80 Danish fox spleen samples.
This suggests that foxes or other wild animals may be linked in some way to the virus’s natural ecology.
However, it is still too early to simply conclude that “foxes transmit the virus to pigs.” The detection of the virus in fox samples could mean that the foxes were infected and replicating the virus, or it could simply indicate temporary viral carriage following predation or environmental exposure. The Danish team also noted that the virus’s pathogenic role in wild animals remains unknown.
More noteworthy is that the viral strains from pig farms in the Netherlands and Denmark are highly similar to each other—even more closely related than they are to viruses found in local wildlife. This suggests a transmission link among pig herds rather than independent spillovers from local wildlife in each country.
If follow-up research confirms this, the focus of the investigation will shift from “occasional spillovers from wildlife” to “transnational transmission within pig herds or related supply chains.”
Cases Have Also Been Detected in Belgium, Germany, and Spain
In addition to Denmark, related reports mention that the virus and the syndrome have been detected at pig farms in Belgium and Germany. An update from PathoSense Diagnostics also states that the virus has been detected in Spain.
This indicates that monitoring efforts are expanding across Europe.
However, publicly available information remains limited at this time. For the cases in Belgium, Germany, and Spain, there is still a lack of detailed data on on-farm epidemiology, clinical severity, viral load, transmission chains, and economic losses. Therefore, it cannot yet be directly defined as a “European pandemic.”
A more prudent statement would be: this new swine syndrome and the associated virus have been detected in multiple European countries, and the scope of transmission and clinical impact are still being confirmed.
A Low Mortality Rate Does Not Equate to Low Losses
Based on current reports, this syndrome is not primarily characterized by a high mortality rate. The Dutch case report also noted that the mortality rate is generally low, with the disease course on a single farm potentially lasting 3–6 months, after which some degree of natural immunity appears to develop.
However, a low mortality rate does not mean that the impact on the industry can be ignored.
The problem with this disease is that it primarily affects piglets and young pigs, manifesting as skin abnormalities, stunted growth, post-weaning diarrhea, and respiratory symptoms. For pig farms, these issues may not necessarily result in large-scale mortality, but they can lead to more subtle production losses:
• Decreased uniformity among piglets;
• Slower growth rates;
• Increased difficulty in post-weaning management;
• Higher proportion of weak and stunted piglets;
• Increased diagnostic costs;
• Losses may be magnified when co-infected with other pathogens.
For intensive pig farms, this type of “survival but poor growth” issue is often harder to identify quickly than a single episode of high mortality, and is more likely to be attributed to management, nutrition, or common pathogen pressure.
A Reminder for China’s Swine Industry
To date, there have been no public reports of similar cases at Chinese pig farms, and there is no need to cause panic.
However, this incident in Europe offers at least three lessons for the domestic swine industry.
First, a new pathogen does not necessarily begin with a high mortality rate.
Many new issues initially manifest as skin abnormalities, stunted growth, post-weaning diarrhea, or uneven growth rates among litters, rather than mass deaths. If pig farms focus solely on mortality rates, they may miss these early warning signs.
Second, a negative result on routine testing does not necessarily mean the absence of a new pathogen.
This novel parvovirus differs from the classic PPV1, and routine PPV testing may not detect it. If clinical symptoms persist but cannot be explained by routine pathogen testing, more advanced pathogen detection methods, such as metagenomic sequencing, should be considered.
Third, vigilance must be maintained regarding cross-border breeding stock, semen, and related supply chains.
If it is confirmed in the future that this virus has spread widely among European pig populations and can spread across regions through pig trade or biological materials, then the entire chain—including breeding stock, semen, personnel, vehicles, and equipment—may become a key focus of prevention and control assessments.
Industry Assessment: Strong Correlation, Cause Undetermined; Has Spread Across Countries, Transmission Chain Unclear
Based on current information, the timeline of this incident is now relatively clear:
First, a guinea pig farm in the Netherlands reported abnormal piglet syndrome in late 2024; Subsequently, in mid-2025, Royal GD reported that approximately 50 pig farms were affected and detected a new variant of the parvovirus; By 2026, the scope of the outbreak in the Netherlands had expanded further; subsequently, Denmark detected a highly similar virus in comparable cases; and recently, reports of detections have also emerged from Belgium, Germany, and Spain.
This is not a major epidemic that has been fully characterized, but neither is it a minor news item to be taken lightly.
There are currently three key issues:
1. Whether this novel parvovirus can consistently reproduce clinical symptoms in challenge trials;
2. Whether there is a common transmission chain linking cases across multiple European countries;
3. Whether the virus can spread across regions via breeding stock, semen, or other commercial channels.
Until these questions are answered, the most prudent assessment for the industry is:
This is a newly emerging porcine syndrome in Europe strongly associated with the novel parvovirus. While it has been detected across national borders, the causal relationship, transmission routes, and production losses are still being confirmed. For pig farms, the greatest risk is not high mortality, but rather the chronic production losses and diagnostic blind spots underlying the low mortality rate.
Disclaimer: Some of the information in this article is sourced from the internet. Sources have been clearly cited, and copyright belongs to the original authors. The content is provided for readers’ reference only. If the rights of the original authors have been infringed, please contact us promptly via comment so we may remove the content!